Medical Research Collaborative, LLC Announces Launch of Website Offering Market Research on the Global Healthcare Sector

ST. PETERSBURG, FL / ACCESSWIRE / June 3, 2019 / Medical Research Collaborative, LLC (MRC) announces the recent launch of their website, MedicalResearchCollaborative.com.

MRC offers comprehensive segmental market research that includes companies comprising the global healthcare market, segmented into product type by sponsor and by end user. By the mode of product type, the market has been segmented into finished products, active pharmaceutical ingredients and indications approved/sought. The analysis also covers barriers to entry, ongoing patent infringement proceedings, competition and loopholes available to smaller competitors. The analysis further divides amongst products and infers the likelihood and type of regulatory action.

For more information on Medical Research Collaborative reports, please visit: https://medicalresearchcollaborative.com/reports

About Medical Research Collaborative

Medical Research Collaborative, LLC, as the name implies, is a collaborative effort, bringing together expertise from various fields of scientific endeavor, as well as in matters of foreign and domestic (U.S.) patent law and regulatory science, directly applicable to a systematic, thorough analysis of companies in the healthcare sector and their products.

CONTACT

James Murphy
Executive Director of Marketing
Medical Research Collaborative, LLC
Phone: 1-877-427-1317
Email: admin@medicalresearchcollaborative.com
Web: https://medicalresearchcollaborative.com/
Source: https://medicalresearchcollaborative.com/

SOURCE: Medical Research Collaborative, LLC

View source version on accesswire.com:
https://www.accesswire.com/547472/Medical-Research-Collaborative-LLC-Announces-Launch-of-Website-Offering-Market-Research-on-the-Global-Healthcare-Sector

user

Recent Posts

Global Microscopy Market to Reach USD 10.6 Billion by 2029 driven by Healthcare Innovations | MarketsandMarkets™

CHICAGO, July 4, 2024 /PRNewswire/ -- The global microscopy market is poised for significant growth, expected…

17 hours ago

FSD Pharma Files Amended and Restated Material Change Report

Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE)…

20 hours ago

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) -- Global biotechnology leader CSL Behring (ASX: CSL)…

20 hours ago

ICPO Foundation partners with Nuclear Medicine Research Infrastructure (NuMeRI) to establish an ICPO Collaborating Center

ICPO Center NuMeRI ICPO Foundation signed the contract with Nuclear Medicine Research Infrastructure (NuMeRI) to…

20 hours ago